Ann: Phase I Clinical Trial Dosing Update No 3, page-34

  1. 1,183 Posts.
    lightbulb Created with Sketch. 151
    Rise is coming from major shareholders and management not pip traders like yourself.

    Yes with management, CEO and major shareholders all buying up and results of final cohort in next 2 weeks clearing safety in humans and AGN CEO comes out to admit it essentially works in the same way as NYR and will be combined together in the future but it’s going back to 14 million market cap while AGN rerates to a 200-300 million market cap. Absolute genius you are. You deserve a pat on your back for your amazing posts
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
24.0¢
Change
0.005(2.13%)
Mkt cap ! $51.67M
Open High Low Value Volume
23.5¢ 26.5¢ 23.5¢ $267.7K 1.094M

Buyers (Bids)

No. Vol. Price($)
2 60000 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 4000 1
View Market Depth
Last trade - 14.06pm 18/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.